Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,435 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Healthcare Services Mid (2.3bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 0–15%
SE Vimian Group AB (VIMIAN)
Healthcare Services Mid (2.2bn) -1–5 $10M–$100M 50%+ 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
US Zymeworks Inc (ZYME)
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $100K–$1M 0–15% 0–15%
AU Ansell Ltd (ANN)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
CH Idorsia Ltd (IDIA)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
IN Shilpa Medicare Ltd (SHILPAMED)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US NuVasive Inc (NUVA)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
CH BB Biotech AG (BION)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.0bn) 0 Aucune activité — 15–50%
US Absci Corp (ABSI)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (2.0bn) 0 Aucune activité — 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 50%+
SE Elekta AB (publ) (EKTA-B)
Healthcare Services Mid (2.0bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (2.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 0–15%
Healthcare Services Small (2.0bn) 0 Aucune activité — 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 50%+
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
FR Emeis SA (EMEIS)
Healthcare Services Small (1.9bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Septerna Inc (SEPN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
US Biohaven Ltd (BHVN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
BE Galapagos NV (GLPG)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
US Novavax, Inc. (NVAX)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 < $100K 0–15% 0–15%
US Luminex Corp (LMNX)
Healthcare Services Small (1.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Small (1.7bn) -6–10 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
SE Ambea AB (publ) (AMBEA)
Healthcare Services Small (1.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.6bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.6bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.6bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.6bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 -$10M–$100M -0–15% 15–50%
US Innoviva Inc (INVA)
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%